pioglitazone has been researched along with Brain Injuries, Diffuse in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Brain Injuries, Diffuse: Brain injuries occurring over a wide area instead of specific focal area.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M | 1 |
| Bachstetter, AD | 1 |
| Cass, WA | 1 |
| Lifshitz, J | 1 |
| Bing, G | 1 |
1 other study available for pioglitazone and Brain Injuries, Diffuse
| Article | Year |
|---|---|
Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury.
Topics: Animals; Brain Injuries, Diffuse; Cell Survival; Dopaminergic Neurons; Inflammation; Inflammation Me | 2017 |